CHEMM — ChemoMetec A/S Income Statement
0.000.00%
- DKK11.91bn
- DKK11.62bn
- DKK511.06m
Annual income statement for ChemoMetec A/S, fiscal year end - June 30th, DKK millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | R2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | DAS | DAS | DAS | DAS | DAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 428 | 444 | 408 | 496 | 511 |
| Cost of Revenue | |||||
| Gross Profit | 343 | 351 | 321 | 412 | 424 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 226 | 214 | 239 | 259 | 260 |
| Operating Profit | 203 | 231 | 169 | 237 | 251 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 203 | 230 | 177 | 225 | 258 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 159 | 179 | 136 | 175 | 202 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 159 | 179 | 136 | 175 | 202 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 159 | 179 | 136 | 175 | 202 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 9.16 | 10.3 | 7.83 | 10 | 11.6 |
| Dividends per Share |